- 2019
-
Press releases - 16.09.2019
Inserm: sport and health, a winning combination
Over the last few years, Inserm has become a world leader in the field of sport and health research. Here we provide an overview of recent work at the Institute to mark the Sport Unlimitech festival for sport and innovation, which is being held in Lyon from September 19-21, 2019, in partnership with Inserm.
-
Press releases - 16.09.2019
Alain Eychène, head of Research and Innovation at the French National Cancer Institute and head of the Aviesan Multi-Organization Institute for Cancer
Inserm Research Director Alain Eychène is taking the helm at the French National Cancer Institute’s Research and Innovation division. In this new role, he will also head the Aviesan Multi-Organization Institute (ITMO) for cancer and will manage Inserm’s Cancer institute.
-
Press releases - 16.09.2019
Update : Jeanne Calment the oldest woman
un nouveau travail publié dans the journal of gerontology
-
What's on? - 16.09.2019
Update : Jeanne Calment the oldest woman
Update on 16/09/2019 A new article published in the journal The Journal of Gerontology by Jean-Marie Robine, research director at Inserm and his Swiss and Danish colleagues, reaffirms that Jeanne Calment’s identity has not been usurped and that she died at the age 122 years old. In order to show this, they have: – provided […]
-
Press releases - 04.09.2019
Rôle des consultations génétiques dans le diagnostic des enfants et des adolescents atteints de troubles du spectre de l’autisme
Les recherches sur l’origine génétique des troubles du spectre de l’autisme (TSA) se sont significativement développées ces dernières années. Cependant, de nombreux patients concernés n’en bénéficient pas encore systématiquement. Une étude met en évidence l’intérêt d’étendre le dépistage génétique à un nombre plus important de patients souffrant de TSA avec déficit intellectuel.
-
News in brief - 04.09.2019
Cryotherapy: Very Few Proven Benefits but Very Real Side Effects
In 2010, Inserm and the French Directorate-General of Health signed a partnership agreement to evaluate the health benefits of various forms of alternative medicine practiced in France. In a new report published today, researchers from Inserm focused on cryotherapy, a technique in which the body is exposed for 2 to 3 minutes to intense cold ranging […]
-
News in brief - 19.08.2019
Orthoptic Training and Reduced Screen Exposure: A Winning Combination for Treating Vergence Disorder-Induced Dizziness in Children
In order to see objects clearly, our eyes need to be able to work together by superimposing the images perceived by each eye: by rotating inwards (convergence) when the object is close, and by releasing this convergence when switching to object farther away. This ability of our eyes to perform symmetrical and coordinated movements (at […]
-
News in brief - 06.08.2019
A Potential New Strategy for Treating Tumors
An international team led by Toby Lawrence, Inserm researcher at Unit 1104 Center of Immunology Marseille-Luminy (Inserm / CNRS / Aix-Marseille Université), has developed a potential therapy to reduce tumor size, where previous drugs have failed. Its findings have been published in Journal of Experimental Medicine. Tumors develop from abnormal cells in the body that […]
-
Press releases - 24.07.2019
Partially hydrolysed (hypoallergenic) baby formulas do not reduce allergy risks in infants
Hypoallergenic formulas are recommended for infants who are not exclusively breastfed and who are at risk of developing allergies. While it is assumed that such formulas reduce the development of allergies later in life, it is unclear whether this claim is true. A team of INRA and INSERM researchers have shown that the consumption of partially hydrolysed (hypoallergenic) formulas was not associated with a reduced risk of developing allergies, findings that were recently published in the journal Pediatric Allergy and Immunology.
-
Press releases - 18.07.2019
New prebiotics: benefits without the downsides?
A research group led by Matteo Serino, Inserm researcher at the Digestive Health Research Institute (Inserm/Inra/ENVT/UT3 Paul Sabatier), has recently shown three plant extracts to have prebiotic effects in obese/diabetic mice, with a shorter duration of treatment and at lower doses to the prebiotics currently in use.